Trokendi XR is a prescription drug approved by the Food and Drug Administration (FDA) to treat several types of seizures in people age 6 and older. Trokendi XR may be prescribed as monotherapy (without other drugs) or adjunctive (with other drugs) therapy in cases of partial onset seizures or primary generalized tonic-clonic seizures. In seizures associated with Lennox-Gastaut Syndrome, Trokendi XR may be prescribed as adjunctive therapy. Trokendi XR is also referred to by its drug name, Topiramate.
Trokendi XR is an anticonvulsant, or drug that prevents seizures. It is believed that Trokendi XR works in cases of epilepsy by inhibiting nerve signals.
How do I take it?
Trokendi XR is generally taken once a day.
Trokendi XR comes in the form of extended-release capsules.
The FDA-approved label for Trokendi XR lists common side effects including dizziness, drowsiness, fatigue, memory problems, difficulty concentrating, headache, nervousness, vision changes, fever, pins-and-needles sensation, slowed movements, speech disorders, loss of appetite, and weight loss.
Rare but serious side effects listed for Trokendi XR include cognitive dysfunction, kidney stones, lowered body temperature, metabolic imbalance, suicidal ideation and behavior, and severe eye problems potentially leading to permanent vision loss.
For answers to frequently asked questions about exposure to Topiramate during pregnancy and breastfeeding, visit the experts at MothertoBaby.org.
For more details about this treatment, visit:
Trokendi XR – Supernus